The CC genotype of the angiotensin II type i receptor gene independently associates with acute myocardial infarction in a Tunisian population

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 4, 2011, Pages 595-600

  Mehri, Sounira ^a,b   Mahjoub, Sinda ^b   Finsterer, Josef ^c   Zaroui, Amira ^d   Mechmeche, Rachid ^d   Baudin, Bruno ^e   Hammami, Mohamed ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c DANUBE UNIVERSITY KREMS   (Austria)

^d LA RABTA HOSPITAL   (Tunisia)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

Acute myocardial infarction (AMI); angiotensin II type 1 receptor (ATR1) gene; cardiac troponin I (cTnI); polymorphism; serum angiotensin converting enzyme (ACE) activity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; TROPONIN I; TUNISIA;

EID: 79958022320     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320310391833     Document Type: Article

References (28)

1. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease. J Am Coll Cardiol. 2006 ; 48: 1-11
2. Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension. 2001 ; 38: 635-638
3. Millan MA, Kiss A, Aguilera G. Developmental changes in brain angiotensin II receptors in the rat. Peptides. 1991 ; 12: 723-737
4. Kuizinga MC, Smits JF, Arends JW, Daemen MJAP. AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol. 1998 ; 30: 425-434 (Pubitemid 28116322)
5. Paxton WC, Runge M, Horaist C, Cohen C, Alexander RW, et al. Immunohistochemical localization of rat angiotensin II at 1 receptor. Am J Physiol. 1993 ; 264: 989-995
6. Krieger EM, Santos RAS. Angiotensinas: Aspectos fisiológicos. Hipertensão. 1998 ; 1: 7-10
7. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994 ; 24: 63-69 (Pubitemid 24195405)
8. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, et al. Synergistic effects of angiotensinconverting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994 ; 344: 910-913 (Pubitemid 24295876)
9. Smaoui M, Hammami S, Chaaba R, Attia N, Hamda KB, Masmoudi AS, et al. Lipids and lipoprotein (a) concentration in Tunisian type 2 diabetic patients relationship to glycaemic control and coronary heart disease. J Diabetes Complicat. 2004 ; 18: 258-263 (Pubitemid 39165431)
10. Bénéteau-Burnat B, Baudin B. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci. 1991 ; 28: 337-356
11. Baudin B, Bénéteau-Burnat B, Crayon B, Giboudeau J. Automated kinetic assay of angiotensin-converting enzyme on Synchron CX-4. Clin Chem Enzym Comms. 1995 ; 7: 41-48
12. Hingorani AD, Brown MJ. A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene. Biochem Biophys Res Commun. 1995 ; 213: 725-729
13. Pullareddy BR, Srikanth Babu BMV, Karunakar KV, Yasovanthi J, Kumar PS, Sharath A, et al. Angiotensin II type 1 receptor gene polymorphism in myocardial infarction patients. J Renin Angiotensin Aldosterone Syst. 2009 ; 10: 174-178
14. Ulgen MS, Ozturk O, Yazici M, Kayrak M, Alan S, Koç F, et al. Association between A/C1166 gene polymorphism of the angiotensin II type 1 receptor and biventricular functions in patients with acute myocardial infarction. Circ J. 2006 ; 70: 1275-1279 (Pubitemid 44453219)
15. Araújo MA, Menezes BS, Lourenço C, Cordeiro ER, Gatti RR, Goulart LR. The A1166C polymorphism of the angiotensin II type-1 receptor in acute myocardial infarction. Arq Bras Cardiol. 2004 ; 83: 409-413
16. Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, et al. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost.. 2000 ; 83: 212-216
17. Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (ATR1) locus and myocardial infarction. Clin Genet. 1997 ; 52: 71-76 (Pubitemid 27344785)
18. Ranjith N, Pegoraro RJ, Rom L, Lanning PA, Naidoo DP. Renin-angiotensin system and associated gene polymorphisms in myocardial infarction in young South African Indians. Cardiovasc J S Afr. 2004 ; 15: 22-26 (Pubitemid 38418418)
19. Jones A, Dhamrait SS, Payne JR, Hawe E, Li P, Toor IS, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension. 2003 ; 42: 500-506 (Pubitemid 37237345)
20. Buraczyńska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska-Czekajska T, et al. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol. 2003 ; 58: 1-9
21. Takami S, Imai Y, Katsuya T, Ohkubo T, Tsuji I, Nagai K, et al. Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction. The Ohasama study. Am J Hypertens. 2000 ; 13: 121-127 (Pubitemid 30125633)
22. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet. 2006 ; 7: 42-50
23. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvetti M, et al. Angiotensin II type 1 receptor A/C1166 polymorphism: Relationships with blood pressure and cardiovascular structure. Hypertension. 1996 ; 28: 1076-1080 (Pubitemid 26415827)
24. Pfeffer M. Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers. Am Heart J. 2000 ; 139: S23 - S28
25. Mehri S, Baudin B, Mahjoub S, Zaroui A, Bénéteau-Burnat B, Mechmeche R, et al. Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population. Genet Test Mol Biomarkers. 2010 ; 14: 85-91
26. Nickenig G, Harrison DG. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation. Circulation. 2002 ; 105: 530-536 (Pubitemid 34262669)
27. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II mediated mitochondrial dysfunction. Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2008 ; 102: 488-496 (Pubitemid 351651106)
28. Komajda M, Jais JP, Reeves F, Goldfarb B, Bouhour JB, Juillieres Y, et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J. 1990 ; 11: 824-831 (Pubitemid 20321335)